ATE202675T1 - Nährungserganzungmittel - Google Patents

Nährungserganzungmittel

Info

Publication number
ATE202675T1
ATE202675T1 AT98912704T AT98912704T ATE202675T1 AT E202675 T1 ATE202675 T1 AT E202675T1 AT 98912704 T AT98912704 T AT 98912704T AT 98912704 T AT98912704 T AT 98912704T AT E202675 T1 ATE202675 T1 AT E202675T1
Authority
AT
Austria
Prior art keywords
camitine
carnitine
individuals
nutritional supplements
udergoing
Prior art date
Application number
AT98912704T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Application granted granted Critical
Publication of ATE202675T1 publication Critical patent/ATE202675T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/80—Geriatric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/806—Salt or mineral substitute

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98912704T 1997-04-01 1998-03-27 Nährungserganzungmittel ATE202675T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000185A IT1291127B1 (it) 1997-04-01 1997-04-01 Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
PCT/IT1998/000069 WO1998043499A2 (en) 1997-04-01 1998-03-27 Nutritional supplement

Publications (1)

Publication Number Publication Date
ATE202675T1 true ATE202675T1 (de) 2001-07-15

Family

ID=11404926

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98912704T ATE202675T1 (de) 1997-04-01 1998-03-27 Nährungserganzungmittel

Country Status (19)

Country Link
US (1) US6245378B1 (de)
EP (1) EP0973415B1 (de)
JP (1) JP2001517085A (de)
KR (1) KR20010005865A (de)
CN (1) CN1074912C (de)
AT (1) ATE202675T1 (de)
AU (1) AU729412B2 (de)
BR (1) BR9807905A (de)
CA (1) CA2285332C (de)
DE (1) DE69801047T2 (de)
DK (1) DK0973415T3 (de)
ES (1) ES2159179T3 (de)
GR (1) GR3036777T3 (de)
HK (1) HK1026124A1 (de)
IL (1) IL131857A (de)
IT (1) IT1291127B1 (de)
PT (1) PT973415E (de)
SK (1) SK282907B6 (de)
WO (1) WO1998043499A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2146555B1 (es) * 1999-01-22 2001-03-01 Helsint S A L Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico.
IT1306173B1 (it) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
IT1306179B1 (it) 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
AU1800801A (en) * 1999-11-17 2001-05-30 Eric H. Kuhrts Exercise and muscle enhancement formulations
US6429230B1 (en) * 2000-01-19 2002-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
US6914076B2 (en) * 2000-01-19 2005-07-05 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
US6335369B1 (en) * 2000-01-19 2002-01-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treating chronic uremic patients undergoing periodical dialysis
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
IT1317043B1 (it) 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
AU9093901A (en) * 2000-09-14 2002-03-26 Univ Nebraska Creatine ester pronutrient compounds and formulations
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US20020150627A1 (en) * 2001-01-26 2002-10-17 Stout Jeffrey Ray Composition containing creatine and phosphorus
DE10133200A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US6652891B2 (en) 2001-12-12 2003-11-25 Herbasway Laboratories, Llc Co-enzyme Q10 dietary supplement
ITRM20020194A1 (it) 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US7776913B2 (en) * 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
DE20321010U1 (de) * 2003-03-28 2005-12-29 Schymura, Martin Fruchtgummizusammensetzung
JP2006137746A (ja) * 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
EP1871883A1 (de) * 2005-03-02 2008-01-02 Metanomics GmbH Verfahren zur produktion von feinchemikalien
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
EP1973426A2 (de) * 2005-11-03 2008-10-01 Southwest Immunology Inc. Zusammensetzungen für die vorbeugung und linderung von muskelkater
US20070248648A1 (en) * 2006-04-20 2007-10-25 Next Proteins, Inc. High protein, fatigue reducing powder
US10426750B1 (en) 2007-09-18 2019-10-01 Thermolife International, Llc Amino acid supplement formulations
US10646508B1 (en) 2007-09-18 2020-05-12 Thermolife International, Llc Method of safely administering nitrate dietary supplements and compositions
US10435356B1 (en) 2007-09-18 2019-10-08 Thermolife International, Llc Amino acid compositions
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US10426792B1 (en) * 2007-09-18 2019-10-01 Thermolife International, Llc Amino acid compositions
CN101524155B (zh) * 2009-04-20 2012-10-10 北京康比特体育科技股份有限公司 一种氨基酸组合物
JP2014532032A (ja) * 2011-04-05 2014-12-04 ロンザ・リミテッド 疲労を減少させるためまたは予防するためおよび認知機能を改善するためのｌ−カルニチン、その塩および誘導体の使用
EP2508179A1 (de) * 2011-04-05 2012-10-10 Lonza Ltd. Verwendung von L-Carnitin, Salzen und Derivaten davon zur Verringerung oder Vorbeugung von Ermüdung und zur Verbesserung der kognitiven Funktion
AU2012242565B2 (en) 2011-04-13 2017-05-11 Thermolife International, Llc N-Acetyl Beta Alanine methods of use
CN102512655B (zh) * 2011-11-30 2013-10-30 北京康比特体育科技股份有限公司 左旋肉碱组合物和制剂，及其制备方法和应用
WO2014045065A2 (en) * 2012-09-22 2014-03-27 Bslim Holdings Limited Dietary compositions and their uses
CN103271350B (zh) * 2013-03-04 2014-09-24 中国航天员科研训练中心 空间站航天员太空高能压缩食品及其制法
GB201304112D0 (en) * 2013-03-07 2013-04-24 Univ Nottingham Modulation of energy expenditure
CN104415043B (zh) * 2013-09-03 2017-03-15 上海华拓医药科技发展有限公司 一种磷酸肌酸二钠盐在制备抗癌因性疲乏药物中的用途
BR112016028654A2 (pt) * 2014-06-12 2018-07-10 Lonza Ag método para diminuição de dano muscular esquelético e / ou estresse oxidativo em mamíferos
WO2017075289A1 (en) 2015-10-27 2017-05-04 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CA3008033A1 (en) * 2015-12-18 2017-06-22 Lonza, Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals
AU2019357838A1 (en) * 2018-10-10 2021-04-15 So Ngor Sally LEUNG Health product composition for supplementing deficiency, preparation method therefor and application thereof
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
US20220313644A1 (en) * 2021-04-06 2022-10-06 Celagenex Research (India) Pvt. Ltd. Synergistic composition for potentiating stabilized atp
CN118638020A (zh) * 2024-08-08 2024-09-13 杭州海尔希畜牧科技有限公司 L-天门冬氨酸l(-)肉碱(1:1)的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400371A (en) * 1972-11-06 1983-08-23 Biocarn Ltd. Carnitine and its use in reducing cardiac toxicity and as a synergist with cytostats
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
US4346107A (en) 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1119853B (it) * 1979-09-21 1986-03-10 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente l-carnitina per il trattamento delle dislipidemie ed iperlipo proteinemie
IT1119854B (it) * 1979-09-21 1986-03-10 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente l-carnitina per il trattamento di disfunzioni cardiache
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
DE3463261D1 (en) * 1983-12-28 1987-05-27 Sigma Tau Ind Farmaceuti Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
DE3420828A1 (de) * 1984-06-05 1985-12-05 Bayer Ag, 5090 Leverkusen Fungizide mittel
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
ATE88631T1 (de) * 1986-09-17 1993-05-15 Clintec Nutrition Co Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi
IT1258491B (it) * 1992-09-24 1996-02-26 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders

Also Published As

Publication number Publication date
WO1998043499A3 (en) 1999-01-07
SK282907B6 (sk) 2003-01-09
IL131857A (en) 2002-04-21
HK1026124A1 (en) 2000-12-08
CN1251496A (zh) 2000-04-26
IT1291127B1 (it) 1998-12-29
GR3036777T3 (en) 2002-01-31
BR9807905A (pt) 2000-02-22
AU6746298A (en) 1998-10-22
DE69801047T2 (de) 2001-10-31
EP0973415A2 (de) 2000-01-26
WO1998043499A2 (en) 1998-10-08
CA2285332C (en) 2007-11-27
SK134999A3 (en) 2000-05-16
ES2159179T3 (es) 2001-09-16
DE69801047D1 (de) 2001-08-09
CA2285332A1 (en) 1998-10-08
EP0973415B1 (de) 2001-07-04
US6245378B1 (en) 2001-06-12
ITRM970185A1 (it) 1998-10-01
IL131857A0 (en) 2001-03-19
PT973415E (pt) 2001-10-30
JP2001517085A (ja) 2001-10-02
DK0973415T3 (da) 2001-09-24
CN1074912C (zh) 2001-11-21
AU729412B2 (en) 2001-02-01
KR20010005865A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
ATE202675T1 (de) Nährungserganzungmittel
CA2284738A1 (en) Nutritional composition for improvements in cell energetics
CA2221455A1 (en) Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
NO990940D0 (no) Ernµringssammensetning for fenylketonuripasienter
NZ509276A (en) Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
CA2377128A1 (en) Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise
CA2244608A1 (en) Nutritional product with high fat, low carbohydrate and amino acid imbalance
WO1999048384A3 (en) Food containing biotin and other b vitamins
EP0747039A3 (de) Mittel gegen Sonnenlicht und Erytheme auf der Basis von natürlichen Produkten
PT948328E (pt) Composicoes a base de aminoacidos
DE60103055D1 (de) Nahrungsergänzung zur verbesserung des muskelenergiestoffwechsels, enthaltend alkanoyl-carnitine und ribose
PT1289931E (pt) Sais duplos de acido fumarico com uma carnitina e um aminoacido e suplementos alimentares, suplementos dieteticos e farmacos contendo os mesmos
BR9810250A (pt) Alimento dietético ou ração, suplemento dietético, e, processo para preparação e uso de um alimento dietético, ração ou suplemento.
WO2001039743A3 (en) Milk or milk products supplemented with a carnitine
Ashley et al. Amino acid-enriched plasteins: a source of limiting amino acids for the weanling rat
CA2285490A1 (en) Composition for improvement of cellular nutrition and mitochondrial energetics
AU5366699A (en) Food supplements comprising lipoic acid and creatine and methods for their use
ATE298205T1 (de) Zusammensetzung zur leistungsförderung bei sportlicher tätigkeit, ihre herstellung und verwendung als diätetisches lebensmittel
Baker Department of Animal Sciences and Division of Nutritional Sciences, University of fllinois Urbana, IL 61801
KR960036952A (ko) 육류식품 제조방법
ES2137893A1 (es) Composicion capaz de estimular el desarrollo del color de la piel y pulpa en frutas y hortalizas.
ITRM980726A0 (it) Composizione sotto forma di integratore alimentare, supporto dietetico o farmaco comprendente l-carnitina fumarato quale principio attivo